This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Nicole Lawrence, PhD
Senior Research Fellow at Institute for Molecular Bioscience and Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland
Speaker

Profile

Dr Nicole Lawrence obtained a BSc from James Cook University of North Queensland and an Honours degree and PhD from the University of Queensland, Australia. She has undertaken postdoctoral roles at the University of British Columbia in Canada, and Protagonist Therapeutics and the Institute of Molecular Bioscience in Australia. Dr Lawrence is currently a senior research fellow in Professor David Craik’s lab at the Institute for Molecular Bioscience where she leads the development of peptide-based antimalarial drugs. She enjoys working with interdisciplinary teams at the interface of chemistry and biology to leverage the potential of peptides for developing next-generation medicines that selectively target infected cells and are less likely to induce development of drug resistance.